U.S. Markets open in 4 hrs 59 mins

Cambrex Corporation (CBM)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
54.25+0.20 (+0.37%)
At close: 4:02PM EDT
People also watch

Cambrex Corporation

One Meadowlands Plaza
East Rutherford, NJ 07073
United States

Full Time Employees1,295

Key Executives

Mr. Steven M. KloskChief Exec. Officer, Pres and Director1.96M2.08M60
Mr. Shawn P. CavanaghChief Operating Officer and Exec. VP1.51M1.14M51
Ms. Samantha M. HanleyVP, Gen. Counsel and Corp. Sec.569.92kN/A39
Mr. Gregory P. SargenExec. VP of Corp. Devel. & Strategy1.42M816.62k51
Mr. Tom G. VadakethChief Financial Officer and Exec. VPN/AN/A54
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. The company’s products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. It serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

Corporate Governance

Cambrex Corporation’s ISS Governance QualityScore as of September 1, 2017 is 2. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 1; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.